首页 > 市场调查报告书 > 製药

眼科药物

欧洲眼药水市场预测至 2030 年 - 区域分析 - 按类型（抗生素、人工泪液、激素等）、应用和购买模式（非处方药和处方药）

市场调查报告书

商品编码

1402540

欧洲眼药水市场预测至 2030 年 - 区域分析 - 按类型（抗生素、人工泪液、激素等）、应用和购买模式（非处方药和处方药）

Europe Eye Drops Market Forecast to 2030 - Regional Analysis - by Type (Antibiotics, Artificial Tears, Hormones, and Others), Application, and Purchase Mode (OTC and Prescription)

出版日期: 2023年11月07日 | 出版商:

The Insight Partners | 英文 99 Pages | 订单完成后即时交付

价格

简介目录图表

欧洲眼药水市场预计将从2022年的34.9663亿美元成长到2030年的50.9311亿美元。预计2022年至2030年CAGR为4.8%。

与年龄相关的眼部疾病的高发生率推动了欧洲眼药水市场

眼睛视力下降主要是由老化引起的。根据世界卫生组织的《世界视力报告》，随着全球人口老化，视力障碍已成为一个重要的公共卫生议题。 2020 年，有 110 亿人患有未矫正的老花眼或远端视力障碍。预计到 2050 年，这一数字将增加至 180 亿。白内障、老年黄斑部病变、青光眼、糖尿病视网膜病变和老花眼是视力障碍的常见原因，在晚年（> 60 岁）更常见。儘管在过去30 年中，视力障碍和失明的年龄标准化盛行率有所下降，但这种下降已被人口的迅速老化所抵消，导致全球失明和视力障碍的人数激增，其中主要是2000 年以上的成年人。60 岁以上。因此，老年人眼病的高盛行率可能会鼓励製造商在市场上推出新的眼部护理产品，这反过来又将有助于市场的成长。此外，医疗保健产业的发展也提高了预期寿命。各种医疗保健公司设计针对老年族群的产品。世界各国正在采用新技术来安全有效地治疗老年人。因此，人口老化的加剧正在推动市场的成长。

欧洲眼药水市场概况

欧洲的欧洲眼药水市场分为德国、英国、法国、义大利、西班牙和欧洲其他地区。该地区在欧洲滴眼剂市场中占有重要份额。该地区的市场成长归因于欧洲国家各种国内参与者的不断增加以及干眼症患者的不断上升。德国有许多人患有眼部疾病。此外，该国老年族群中干眼症的发生率正在增加。青光眼是导致大众干眼症的另一个主要因素。德国记录了青光眼、白内障和视网膜剥离等眼科疾病的广泛发生。根据2021年5月发表在《眼科杂誌》上的文章《德国视网膜脱离的发生率：古腾堡健康研究的结果》，德国视网膜脱离疾病的发生率为每年每10万人中42人35-74岁。与其他欧洲国家的估计相比，该研究预计德国这个年龄层的视网膜剥离发生率更高。

根据联邦统计局(Destatis) 的数据，到2021 年底，德国67 岁及以上人口约为1,620 万人，预计到2060 年这一数字将增至2,160 万人。此外，疾病和视力问题在德国人中较常见。老年人。未来几年，随着德国人口老化的加剧，与眼部相关疾病的发生率预计将增加，从而推动该国欧洲眼药水市场的成长。

欧洲眼药水市场收入及 2030 年预测（百万美元）

欧洲眼药水市场区隔

欧洲眼药水市场按类型、应用、购买模式和国家细分。

根据类型，欧洲眼药水市场分为抗生素、人工泪液、荷尔蒙等。 2022年，抗生素领域在欧洲眼药水市场占有最大份额。

根据应用，欧洲眼药水市场分为眼疾、眼部保健等。到2022年，眼疾细分市场在欧洲眼药水市场中占据最大份额。眼疾细分市场进一步细分为干眼症、青光眼、白内障等。

根据购买模式，欧洲眼药水市场分为非处方药和处方药。 2022 年，处方药细分市场在欧洲眼药水市场中占有更大份额。

根据国家/地区，欧洲眼药水市场分为德国、英国、法国、义大利、西班牙和欧洲其他地区。 2022年，德国在欧洲眼药水市场占据主导地位。

艾伯维公司(AbbVie Inc)、Akorn Operating Company LLC、爱尔康公司(Alcon AG)、博士伦公司(Bausch & Lomb Inc.)、辉瑞公司(Pfizer Inc)、Prestige Consumer Healthcare Inc.、乐敦製药有限公司(Rohto Pharmaceutical Co Ltd)、Sager Pharma Kft. 和Similasan Corp 是欧洲眼药水领域的一些领先公司市场。

Weakening of eye vision is prominently caused by aging. According to the World Health Organization's World Vision Report, with an aging global population, vision impairment has risen to the forefront as a significant public health concern. In 2020, 11 billion people had uncorrected presbyopia or distance vision impairment. This amount is predicted to rise to 18 billion by 2050. Cataracts, age-related macular degeneration, glaucoma, diabetic retinopathy, and presbyopia are common causes of vision impairment that occur more frequently in later life (>60 years). Although, over the last 30 years, the age-standardized prevalence of vision impairment and blindness has reduced, this decrease has been offset by a rapidly aging population, resulting in a surging number of individuals with blindness and vision impairment globally, primarily adults over the age of 60. Thus, the high prevalence of eye disease among the older population is likely to encourage manufacturers to introduce new eye care products in the market, which, in turn, will contribute to the growth of the market. Also, the development in the healthcare industry has increased life expectancy. Various healthcare companies design products focusing on the geriatric population. Countries worldwide are adopting new techniques to treat older people safely and effectively. Thus, the growing aging population is driving the growth of the market.

Europe Eye Drops Market Overview

The Europe eye drops market in Europe is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The region holds a significant share of the Europe eye drops market. The market growth in this region is attributed to the growing presence of various domestic players across European countries and the increasing prevalence of dry eye disease. Numerous people in Germany are living with eye disorders. Also, the incidence of dry eye condition is increasing among the elderly population in the country. Glaucoma is another leading factor causing dry eye condition among masses. Germany records a widespread occurrence of ophthalmic conditions such as glaucoma, cataracts, and retinal detachments. According to the article "Incidence of Retinal Detachment in Germany: Results from the Gutenberg Health Study," published in the Ophthalmological Journal in May 2021, the incidence rate of retinal detachment disease in Germany was 42 per 100,000 people per year for the age group of 35-74 years. Compared to estimates from other European nations, the study projected that Germany has a higher incidence of retinal detachment in this age group.

As per the Federal Statistical Office (Destatis), ~16.2 million people in Germany were age 67 and above by the end of 2021, and the number is projected to rise to 21.6 million by 2060. Furthermore, illnesses and eyesight problems are more common among elderly people. The incidence of eye-related disease is expected to increase with the rising aging population in Germany in the coming years, thus fueling the growth of the Europe eye drops market in the country.

Europe Eye Drops Market Revenue and Forecast to 2030 (US$ Million)

Europe Eye Drops Market Segmentation

The Europe eye drops market is segmented into type, application, purchase mode, and country.

Based on type, the Europe eye drops market is segmented into antibiotics, artificial tears, hormones, and others. The antibiotics segment held the largest share of the Europe eye drops market in 2022.

Based on application, the Europe eye drops market is segmented into eye diseases, eye care, and others. The eye diseases segment held the largest share of the Europe eye drops market in 2022. The eye diseases segment is further segmented into dry eye, glaucoma, cataract, and others.

Based on purchase mode, the Europe eye drops market is segmented into OTC and prescription. The prescription segment held a larger share of the Europe eye drops market in 2022.

Based on country, the Europe eye drops market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe eye drops market in 2022.

AbbVie Inc, Akorn Operating Company LLC, Alcon AG, Bausch & Lomb Inc, Pfizer Inc, Prestige Consumer Healthcare Inc., Rohto Pharmaceutical Co Ltd, Sager Pharma Kft., and Similasan Corp are some of the leading companies operating in the Europe eye drops market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe Eye Drops Market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the Europe Eye Drops Market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Eye Drops Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 Europe PEST Analysis
4.3 Pipeline Analysis

5. Europe Eye Drops Market - Key Industry Dynamics

5.1 Market Drivers
- 5.1.1 Rising Prevalence of Ophthalmic Diseases
- 5.1.2 High Incidence of Age-Related Eye Diseases
5.2 Market Restraints
- 5.2.1 Product Recalls
5.3 Market Opportunities
- 5.3.1 Rising Initiatives for Eye Care
5.4 Future Trends
- 5.4.1 Changing Lifestyle
5.5 Impact Analysis

6. Eye Drops Market - Europe Market Analysis

6.1 Europe Eye Drops Market Revenue (US$ Mn), 2022 - 2030

7. Europe Eye Drops Market - Revenue and Forecast to 2030 - by Type

7.1 Overview
7.2 Europe Eye Drops Market Revenue Share, by Type 2022 & 2030 (%)
7.3 Antibiotics
- 7.3.1 Overview
- 7.3.2 Antibiotics: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Artificial Tears
- 7.4.1 Overview
- 7.4.2 Artificial Tears: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Hormones
- 7.5.1 Overview
- 7.5.2 Hormones: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Others
- 7.6.1 Overview
- 7.6.2 Others: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Eye Drops Market - Revenue and Forecast to 2030 - by Application

8.1 Overview
8.2 Europe Eye Drops Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Eye Diseases
- 8.3.1 Overview
- 8.3.2 Eye Diseases: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.1 Dry Eye
    - 8.3.2.1.1 Overview
  - 8.3.2.2 Dry Eye: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.3 Glaucoma
    - 8.3.2.3.1 Overview
    - 8.3.2.3.2 Glaucoma: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.4 Cataract
    - 8.3.2.4.1 Overview
    - 8.3.2.4.2 Cataract: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.5 Others
    - 8.3.2.5.1 Overview
    - 8.3.2.5.2 Others: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Eye Care
- 8.4.1 Overview
- 8.4.2 Eye Care: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Others
- 8.5.1 Overview
- 8.5.2 Others: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Eye Drops Market - Revenue and Forecast to 2030 - by Purchase Mode

9.1 Overview
9.2 Europe Eye Drops Market Revenue Share, by Purchase Mode 2022 & 2030 (%)
9.3 Prescription
- 9.3.1 Overview
- 9.3.2 Prescription: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
9.4 OTC
- 9.4.1 Overview
- 9.4.2 OTC: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Eye Drops Market - Revenue and Forecast to 2030 - Country Analysis

10.1 Europe Eye Drops Market
- 10.1.1 Overview
- 10.1.2 Europe Eye Drops Market, by Country, 2022 & 2030 (%)
  - 10.1.2.1 Germany: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.1.1 Overview
    - 10.1.2.1.2 Germany: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.1.3 Germany: Europe Eye Drops Market, by Type, 2020-2030 (US$ Million)
    - 10.1.2.1.4 Germany: Europe Eye Drops Market, by Application, 2020-2030 (US$ Million)
    - 10.1.2.1.4.1 Germany: Europe Eye Drops Market, For Eye Diseases by Application, 2020-2030 (US$ Million)
    - 10.1.2.1.5 Germany: Europe Eye Drops Market, by Purchase Mode, 2020-2030 (US$ Million)
  - 10.1.2.2 France: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.2.1 Overview
    - 10.1.2.2.2 France: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.2.3 France: Europe Eye Drops Market, by Type, 2020-2030 (US$ Million)
    - 10.1.2.2.4 France: Europe Eye Drops Market, by Application, 2020-2030 (US$ Million)
    - 10.1.2.2.4.1 France: Europe Eye Drops Market, For Eye Diseases by Application, 2020-2030 (US$ Million)
    - 10.1.2.2.5 France: Europe Eye Drops Market, by Purchase Mode, 2020-2030 (US$ Million)
  - 10.1.2.3 UK: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.3.1 Overview
    - 10.1.2.3.2 UK: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.3.3 UK: Europe Eye Drops Market, by Type, 2020-2030 (US$ Million)
    - 10.1.2.3.4 UK: Europe Eye Drops Market, by Application, 2020-2030 (US$ Million)
    - 10.1.2.3.4.1 UK: Europe Eye Drops Market, For Eye Diseases by Application, 2020-2030 (US$ Million)
    - 10.1.2.3.5 UK: Europe Eye Drops Market, by Purchase Mode, 2020-2030 (US$ Million)
  - 10.1.2.4 Italy: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.4.1 Overview
    - 10.1.2.4.2 Italy: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.4.3 Italy: Europe Eye Drops Market, by Type, 2020-2030 (US$ Million)
    - 10.1.2.4.4 Italy: Europe Eye Drops Market, by Application, 2020-2030 (US$ Million)
    - 10.1.2.4.4.1 Italy: Europe Eye Drops Market, For Antibiotics by Application, 2020-2030 (US$ Million)
    - 10.1.2.4.5 Italy: Europe Eye Drops Market, by Purchase Mode, 2020-2030 (US$ Million)
  - 10.1.2.5 Spain: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.5.1 Overview
    - 10.1.2.5.2 Spain: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.5.3 Spain: Europe Eye Drops Market, by Type, 2020-2030 (US$ Million)
    - 10.1.2.5.4 Spain: Europe Eye Drops Market, by Application, 2020-2030 (US$ Million)
    - 10.1.2.5.4.1 Spain: Europe Eye Drops Market, For Eye Diseases by Application, 2020-2030 (US$ Million)
    - 10.1.2.5.5 Spain: Europe Eye Drops Market, by Purchase Mode, 2020-2030 (US$ Million)
  - 10.1.2.6 Rest of Europe: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.6.1 Overview
    - 10.1.2.6.2 Rest of Europe: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.6.3 Rest of Europe: Europe Eye Drops Market, by Type, 2020-2030 (US$ Million)
    - 10.1.2.6.4 Rest of Europe: Europe Eye Drops Market, by Application, 2020-2030 (US$ Million)
    - 10.1.2.6.4.1 Rest of Europe: Europe Eye Drops Market, For Eye Diseases by Application, 2020-2030 (US$ Million)
    - 10.1.2.6.5 Rest of Europe: Europe Eye Drops Market, by Purchase Mode, 2020-2030 (US$ Million)

11. Europe Eye Drops Market-Industry Landscape

11.1 Overview
11.2 Growth Strategies in the Eye Drops Market (%)
11.3 Organic Developments
- 11.3.1 Overview
11.4 Inorganic Developments
- 11.4.1 Overview

12. Company Profiles

12.1 Alcon AG
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Pfizer Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Prestige Consumer Healthcare Inc.
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Rohto Pharmaceutical Co Ltd
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 AbbVie Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Bausch & Lomb Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Biomedica Pvt Ltd
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Sager Pharma Kft
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Similasan Corp
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments

13. Appendix

13.1 About Us
13.2 Glossary of Terms

简介目录图表

List Of Tables

List of Tables

Table 1. Europe Eye Drops Market Segmentation
Table 2. Germany: Europe Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 3. Germany: Europe Eye Drops Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 4. Germany: Europe Eye Drops Market, For Eye Diseases by Application - Revenue and Forecast to 2030 (US$ Million)
Table 5. Germany: Europe Eye Drops Market, by Purchase Mode - Revenue and Forecast to 2030 (US$ Million)
Table 6. France: Europe Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 7. France: Europe Eye Drops Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 8. France: Europe Eye Drops Market, For Eye Diseases by Application - Revenue and Forecast to 2030 (US$ Million)
Table 9. France: Europe Eye Drops Market, by Purchase Mode - Revenue and Forecast to 2030 (US$ Million)
Table 10. UK: Europe Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 11. UK: Europe Eye Drops Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 12. UK: Europe Eye Drops Market, For Eye Diseases by Application - Revenue and Forecast to 2030 (US$ Million)
Table 13. UK: Europe Eye Drops Market, by Purchase Mode - Revenue and Forecast to 2030 (US$ Million)
Table 14. Italy: Europe Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 15. Italy: Europe Eye Drops Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 16. Italy: Europe Eye Drops Market, For Eye Diseases by Application - Revenue and Forecast to 2030 (US$ Million)
Table 17. Italy: Europe Eye Drops Market, by Purchase Mode - Revenue and Forecast to 2030 (US$ Million)
Table 18. Spain: Europe Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 19. Spain: Europe Eye Drops Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 20. Spain: Europe Eye Drops Market, For Eye Diseases by Application - Revenue and Forecast to 2030 (US$ Million)
Table 21. Spain: Europe Eye Drops Market, by Purchase Mode - Revenue and Forecast to 2030 (US$ Million)
Table 22. Rest of Europe: Europe Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 23. Rest of Europe: Europe Eye Drops Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 24. Rest of Europe: Europe Eye Drops Market, For Eye Diseases by Application - Revenue and Forecast to 2030 (US$ Million)
Table 25. Rest of Europe: Europe Eye Drops Market, by Purchase Mode - Revenue and Forecast to 2030 (US$ Million)
Table 26. Organic Developments in the Eye Drops Market
Table 27. Inorganic Developments in the Eye Drops Market
Table 28. Glossary of Terms, Europe Eye Drops Market

List Of Figures

List of Figures

Figure 1. Europe Eye Drops Market Segmentation, By Country
Figure 2. Europe - PEST Analysis
Figure 3. Pipeline Analysis
Figure 4. Europe Eye Drops Market: Key Industry Dynamics
Figure 5. Europe Eye Drops Market: Impact Analysis of Drivers and Restraints
Figure 6. Europe Eye Drops Market Revenue (US$ Mn), 2020 - 2030
Figure 7. Europe Eye Drops Market Revenue Share, by Type 2022 & 2030 (%)
Figure 8. Antibiotics: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Artificial Tears: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Hormones: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Others: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Europe Eye Drops Market Revenue Share, by Application 2022 & 2030 (%)
Figure 13. Eye Diseases: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Dry Eye: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Glaucoma: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Cataract: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Eye Care: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Others: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Europe Eye Drops Market Revenue Share, by Purchase Mode 2022 & 2030 (%)
Figure 21. Prescription: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. OTC: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Europe Eye Drops Market, by Key Country - Revenue (2022) (US$ Million)
Figure 24. Europe Eye Drops Market, by Country, 2022 & 2030 (%)
Figure 25. Germany: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. France: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. UK: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Italy: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. Spain: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 30. Rest of Europe: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 31. Growth Strategies in the Eye Drops Market (%)